Prilosec Bioequivalence Study in Healthy Volunteers

Completed · Phase 1

Conditions studied: Bioequivalence, AUC, Cmax, Pharmacokinetics

In brief

This is An Open-label, Randomized, Single-center, 4-way Crossover, Single dose Bioequivalence Study Comparing Omeprazole 20 and 40-mg Aqueous solvent Based Capsules Manufactured by AstraZeneca with Omeprazole 20 and 40-mg Organic-solvent Based Capsules Manufactured by Merck

Key facts

Study ID
NCT01921920
Run by
AstraZeneca
People needed
54
Starts
2013-08-01
Expected to finish
2013-11-01
Last updated by the study team
2013-11-25

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.